Immediate Impact

1 by Nobel laureates 5 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Breast cancer: pathogenesis and treatments
2025 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
1 intermediate paper

Works of Zhen Hu being referenced

Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer
2014
A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer
2009

Author Peers

Author Last Decade Papers Cites
Zhen Hu 772 506 412 98 1.5k
Paolo Aretini 777 371 341 87 1.5k
G. Fiorelli 646 460 182 70 1.6k
Edward D. Esplin 826 743 502 116 1.9k
Mandy L. Ballinger 756 384 411 100 1.8k
Laurent Briollais 770 487 274 92 1.8k
Ute Hamann 1079 785 552 66 2.1k
Erling A. Høivik 793 309 340 54 1.6k
Christopher Douville 629 434 373 37 1.2k
Takako Morita 905 355 152 66 2.2k
Hans Guski 623 223 497 99 1.7k

All Works

Loading papers...

Rankless by CCL
2026